TLC 388 T28982
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
TLC 388, a DNA topoisomerase I inhibitor, is used potentially for the treatment of Renal carcinoma and Hepatocellular carcinoma
CAS nr:
1432468-79-5
Purity:
98%
Molecular Weight:
850,71
SMILES:
CC(O/N=C1C2=C(C3=C/1C=C([N+]([O-])=O)C=C3[N+]([O-])=O)C([N+]([O-])=O)=CC([N+]([O-])=O)=C2)C(O[C@](C4=C(CO5)C(N6CC7=CC8=C(CN(C)C)C(O)=CC=C8N=C7C6=C4)=O)(CC)C5=O)=O
Formula:
C39H30N8O15
Pathway:
Target:
